We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Novel Flexible Robotic System to Offer Best-In-Class Endoscopic Visualization

By HospiMedica International staff writers
Posted on 08 Jan 2024
Image: The world’s first flexible robotic surgical system will integrate advanced sensor technology (Photo courtesy of EndoQuest)
Image: The world’s first flexible robotic surgical system will integrate advanced sensor technology (Photo courtesy of EndoQuest)

A revolutionary flexible endoluminal robotic system will combine market-leading sensor technology into its visualization component, ultimately improving patient outcomes and redefining a new standard of care in minimally invasive surgery.

EndoQuest Robotics (Houston, TX, USA), a medical device company pioneering the development of innovative endoluminal robotic technologies, and OMNIVISION (Santa Clara, CA, USA), a developer of semiconductor solutions, including advanced digital imaging, and touch display technology, have entered into a partnership to integrate OMNIVISION's OCHFA CameraCubeChip into EndoQuest's Flexible Robotic System.

To address the unmet needs in gastrointestinal (GI) and other endoluminal surgeries, EndoQuest is developing a novel robotic system that offers precision, flexibility, and improved patient outcomes. The system uses proprietary technology to navigate and perform procedures within the body's natural orifices, including transoral and transanal, thus enabling the least invasive interventions and improving the capabilities of healthcare professionals. As compared to conventional open, laparoscopic, or robotic surgery, which requires incisions through healthy tissue to access the site of surgical intervention, EndoQuest’s revolutionary approach minimizes external incisions and related complications. Incorporating OMNIVISION's market-leading sensor technology into the visualization component of EndoQuest’s first-of-its-kind platform will take patient care and surgical visualization to the next level.

"We are excited to be able to incorporate OMNIVISION's market-leading sensor technology into the visualization component of our first of its kind platform," said Kurt Azarbarzin, CEO of EndoQuest Robotics. "We recognize that advanced imaging is essential to enhancing physician capabilities, especially inside the lumen of the gastrointestinal (GI) tract. OMNIVISION's newest technology is ideal for our Flexible Robotic System."

"We are pleased to integrate our OCHFA CameraCubeChip into the EndoQuest Robotics platform," said Tehzeeb Gunja, OMNIVISION's Director of Medical Marketing. "The OCHFA CameraCubeChip is a high-performance visualization solution built with OMNIVISION's PureCel Plus-S pixel technology, with a small 1.008-micron (µm) pixel size, in a 1/8-inch optical format; it features 720x720 resolution at 30 frames per second. The PureCel Plus-S technology enables high full-well capacity, zero blooming and lower power consumption for crisp, clear life-like images. The OCHFA CameraCubeChip comes in a compact 1.075 x 1.075-millimeter (mm) size, with a 5mm to 50mm focus range and 120-degree diagonal field-of-view that is ideal for GI and other endoluminal procedures. It is a medical-grade, trusted component that undergoes comprehensive certification, qualification and testing, taking patient care and surgical visualization to the next level."

Related Links:
EndoQuest Robotics
OMNIVISION

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
IV Therapy Cart
Avalo I.V Therapy Cart
New
Absorbable Monofilament Mesh
Phasix Mesh

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more